V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 280009465 | 280006737 | 1.83 | 93 | Curative (C) | 2017-01-17 | 2017-01-18 | Dacarbazine | 02 | N | 280025821 | CETUXIMAB + CISPLATIN + FLUOROURACIL |
| 280009466 | 280009496 | 1.73 | null | Palliative (P) | 2018-09-25 | 2018-10-07 | BEP 5 Day | 02 | N | 280025880 | VIDE |
| 280009467 | 280009497 | null | 56.8 | Palliative (P) | null | 2018-07-01 | Cisplatin + Fluorouracil + RT 5day | N | N | 280026332 | PAZOPANIB |
| 280009468 | 280006740 | 1.77 | 115.8 | Adjuvant (A) | null | 2018-03-01 | CISPLATIN + ETOPOSIDE | 02 | N | 280026659 | CARBO + FLUOROURACIL |
| 280009469 | 280006743 | 1.77 | 98 | Neo-adjuvant (N) | 2019-01-07 | 2019-01-09 | ECX | N | null | 280026758 | VIDE |
| 280009470 | 280006745 | null | 80.2 | null | 2015-04-11 | 2015-04-22 | Etoposide IV | N | null | 280026785 | CYCLOPHOSPHAMIDE + VINORELBINE |
| 280009471 | 280006745 | 1.83 | 85 | Palliative (P) | 2013-09-13 | 2013-09-13 | BCG Intravesical | 02 | N | 280026785 | CARBO + FLUOROURACIL |
| 280009472 | 280006745 | null | null | Neo-adjuvant (N) | 2014-05-01 | 2014-06-02 | Etoposide oral | 02 | N | 280026785 | IVADO |
| 280009473 | 280006747 | 1.74 | 87.3 | null | null | 2018-10-12 | IPM | N | N | 280027664 | IDELALISIB |
| 280009474 | 280006747 | null | 0 | null | 2014-02-17 | 2014-02-17 | VINCRISTINE | 02 | N | 280027664 | VIDE |
| 280009475 | 280006749 | 1.04 | 66.3 | Palliative (P) | 2014-07-26 | 2015-02-13 | DACTINOMYCIN + CYCLO + VINCRISTINE | null | null | 280027700 | CISPLATIN + FLUOROURACIL + RT |
| 280009476 | 280006749 | 1.72 | null | Palliative (P) | 2017-04-24 | 2017-04-24 | TRASTUZUMAB | 02 | null | 280027700 | CISPLATIN + FLUOROURACIL + RT |
| 280009477 | 280011484 | 1.5 | 67.4 | Neo-adjuvant (N) | 2014-09-12 | 2014-09-12 | Cyclophosphamide High Dose | N | N | 280027997 | IMATINIB |
| 280009478 | 280011484 | 1.72 | 97 | Curative (C) | null | 2018-01-31 | CARBOPLATIN + FLUOROURACIL | 02 | N | 280027997 | CAPECITABINE |
| 280009479 | 280006750 | 1.52 | 79.2 | null | 2016-07-09 | 2017-11-04 | Gemcitabine + Capecitabine | N | N | 280028043 | PAZOPANIB |
| 280009480 | 280006750 | 1.87 | 92 | Palliative (P) | 2019-01-12 | 2019-01-12 | Capecitabine | N | N | 280028043 | AZACITIDINE |
| 280009481 | 280006751 | 1.65 | 85 | Curative (C) | 2018-07-04 | 2018-07-22 | CAPECITABINE + OXALIPLATIN | null | null | 280028399 | KESTREL TRIAL |
| 280009482 | 280006752 | 0 | 86.9 | null | null | 2014-05-19 | BCG Intravesical | null | null | 280028689 | TEMOZOLOMIDE |
| 280009483 | 280006754 | 1.74 | 93.2 | Palliative (P) | 2013-11-06 | 2013-11-06 | FLUOROURACIL + MITOMYCIN + RT | null | null | 280028689 | GEDDIS TRIAL |
| 280009484 | 280006755 | 1.7 | 18.18 | Palliative (P) | 2018-04-22 | 2018-04-23 | LANREOTIDE | N | N | 280028858 | CARBO + FLUOROURACIL |
| 280009485 | 280009505 | 1.75 | 66.4 | Adjuvant (A) | 2017-08-04 | 2017-08-21 | Etoposide IV | null | null | 280029050 | PEMBROLIZUMAB |
| 280009486 | 280009506 | 1.65 | 73.4 | Curative (C) | null | 2014-07-24 | BENDAMUSTINE + RITUXIMAB | N | N | 280029220 | IVADO |
| 280009487 | 280009506 | 1.74 | 115 | Palliative (P) | 2019-02-06 | 2019-02-06 | BCG Intravesical | N | N | 280029220 | ECX |
| 280009488 | 280006757 | 1.63 | 92 | Palliative (P) | 2016-11-14 | 2017-08-05 | Docetaxel 75mg/m2 (21 day) | N | N | 280029364 | CARBOPLATIN + CETUXIMAB + FU |
| 280009489 | 280006758 | 0 | 58.8 | Palliative (P) | 2017-04-09 | 2017-05-22 | Dacarbazine | 02 | N | 280029448 | DOCETAXEL |
| 280009490 | 280006760 | 1.6 | 67.4 | Curative (C) | 2013-11-16 | 2013-11-16 | Cyclophosphamide High Dose | N | N | 280029532 | CMV |
| 280009491 | 280006761 | 1.68 | 61.6 | Adjuvant (A) | 2013-09-21 | 2013-11-06 | Carboplatin + Vinorelbine IV | N | N | 280029612 | CARBOPLATIN + CETUXIMAB + FU |
| 280009492 | 280006764 | 1.61 | 79.8 | Palliative (P) | 2017-12-14 | 2018-04-10 | STS Rhabdo rel BERNIE Vinor Cyclo | N | N | 280030105 | BUSULFAN + MELPHALAN |
| 280009493 | 280006764 | 1.67 | 69 | Palliative (P) | null | 2014-03-26 | CARBOPLATIN + Cetuximab + FLUOROURACIL | N | null | 280030105 | IRINOTECAN + VINCRISTINE |
| 280009494 | 280006766 | 0 | null | Curative (C) | 2015-07-19 | 2015-07-19 | VIA (Ifos 1.5g/m2) | 02 | N | 280030307 | ECX |
| 280009495 | 280006767 | 1.89 | 89.8 | Palliative (P) | 2019-04-09 | 2019-05-06 | NIVOLUMAB | N | N | 280030458 | CYCLOPHOSPHAMIDE + TOPOTECAN |
| 280009496 | 280006768 | 1.8 | 95.6 | Palliative (P) | 2016-10-24 | 2016-11-15 | VDC | N | N | 280030585 | IRINOTECAN + VINCRISTINE |
| 280009497 | 280006769 | 1.64 | null | Palliative (P) | 2016-09-24 | 2016-10-14 | LANREOTIDE | N | N | 280030585 | CARBO + FLUOROURACIL |
| 280009498 | 280006769 | 1.8 | 81 | Palliative (P) | 2018-12-13 | 2018-12-13 | ECX | 2 | N | 280030585 | CAPECITABINE + OXALIPLATIN |
| 280009499 | 280009510 | 1.78 | 102 | Adjuvant (A) | 2019-08-23 | 2019-08-25 | MITOMYCIN | N | N | 280016093 | IMATINIB |
| 280009500 | 280010836 | 1.71 | 83 | Curative (C) | 2016-12-01 | 2016-12-13 | IVADo | null | null | 280017205 | IRINOTECAN + TEMOZOLOMIDE + VINCRISTINE |
| 280009501 | 280006771 | null | 52.5 | null | null | 2018-02-28 | EOX | N | N | 280017205 | GEDDIS TRIAL |
| 280009502 | 280011488 | 1.69 | null | Palliative (P) | 2018-08-31 | 2018-09-25 | IVADo | 02 | N | 280017406 | CARBOPLATIN + CETUXIMAB + FU |
| 280009503 | 280006772 | 1.7 | 86 | Palliative (P) | 2016-08-28 | 2016-08-28 | Capecitabine | N | N | 280019392 | CYCLOPHOSPHAMIDE + VINCRISTINE |
| 280009504 | 280006773 | null | 74.9 | Palliative (P) | 2017-07-21 | 2017-07-21 | Capecitabine | 02 | N | 280020288 | CETUXIMAB + CISPLATIN + FLUOROURACIL |
| 280009505 | 280006773 | 1.76 | 51 | Neo-adjuvant (N) | 2017-09-14 | 2017-10-11 | Dacarbazine | N | null | 280020288 | ERLOTINIB |
| 280009506 | 280006774 | 1.79 | null | Palliative (P) | 2018-06-02 | 2018-09-25 | CARBOPLATIN + FLUOROURACIL | 02 | N | 280020683 | CISPLATIN + FLUOROURACIL + RT |
| 280009507 | 280006776 | 1.75 | 86 | Palliative (P) | 2015-02-07 | 2015-02-19 | Erlotinib | N | N | 280022482 | CYCLOPHOSPHAMIDE + DACTINOMYCIN + VINCRISTINE |
| 280009508 | 280006776 | 1.76 | 60.6 | Palliative (P) | 2017-05-20 | 2017-06-12 | AXI-STS TRIAL | N | Y | 280022482 | IVADO |
| 280009509 | 280006777 | 1.64 | 100.5 | Curative (C) | 2015-02-19 | 2015-03-03 | Vinorelbine (oral) | 02 | N | 280023556 | VIDE |
| 280009510 | 280006779 | 1.67 | 100.5 | Palliative (P) | null | 2019-02-22 | KESTREL Trial | N | Y | 280023737 | CYCLOPHOSPHAMIDE + VINORELBINE |
| 280009511 | 280009516 | 1.68 | 71.4 | Palliative (P) | 2016-04-04 | 2017-02-12 | DABRAFENIB + TRAMETINIB | N | N | 280023737 | BENDAMUSTINE + RITUXIMAB |
| 280009512 | 280006782 | 1.78 | 141 | Disease modification (D) | 2018-10-22 | 2019-06-17 | ICE + GCSF | 02 | N | 280023786 | VIDE |
| 280009513 | 280006783 | 1.59 | 47 | null | 2017-03-21 | 2017-03-21 | LIPOSOMAL DOXORUBICIN | N | null | 280025115 | CYCLOPHOSPHAMIDE + VINORELBINE |
| 280009514 | 280006783 | 1.78 | 55 | Curative (C) | 2017-09-23 | 2017-10-14 | Rituximab | 2 | N | 280025115 | CARBO + FLUOROURACIL |